BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809
2199 results:

  • 1. [Neurofibromatosis type 1 associated with pheochromocytoma: a case report with a brief review of the literature].
    Lugovskaya AY; Britvin TA; Gurevich LE; Rog IS; Nefedova LN; Ilovayskaya IA
    Probl Endokrinol (Mosk); 2023 Sep; 70(2):53-64. PubMed ID: 38796761
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. GZ17-6.02 kills PDX isolates of uveal melanoma.
    Booth L; Roberts JL; Spasojevic I; Baker KC; Poklepovic A; West C; Kirkwood JM; Dent P
    Oncotarget; 2024 May; 15():328-344. PubMed ID: 38758815
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeted inhibition of branched-chain amino acid metabolism drives apoptosis of glioblastoma by facilitating ubiquitin degradation of Mfn2 and oxidative stress.
    Lu Z; Sun GF; He KY; Zhang Z; Han XH; Qu XH; Wan DF; Yao D; Tou FF; Han XJ; Wang T
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167220. PubMed ID: 38718847
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. YANK2 activated by Fyn promotes glioma tumorigenesis via the mtor-independent p70S6K activation pathway.
    Shi Y; Cheng Y; Wang W; Tang L; Li W; Zhang L; Yuan Z; Zhu F; Duan Q
    Sci Rep; 2024 May; 14(1):10507. PubMed ID: 38714727
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines.
    Stouffer M; Wandling E; Dickson L; Lin S; Duan H; Powe E; Jean-Louis D; Tiwari AK; Amos S
    Cancer Rep (Hoboken); 2024 May; 7(5):e2051. PubMed ID: 38702989
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Small-molecule Molephantin induces apoptosis and mitophagy flux blockage through ROS production in glioblastoma.
    Ling Z; Pan J; Zhang Z; Chen G; Geng J; Lin Q; Zhang T; Cao S; Chen C; Lin J; Yuan H; Ding W; Xiao F; Xu X; Li F; Wang G; Zhang Y; Li J
    Cancer Lett; 2024 Jun; 592():216927. PubMed ID: 38697460
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The
    Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1.
    Ren X; Deng D; Xiang S; Feng J
    Aging (Albany NY); 2024 Apr; 16(8):7174-7187. PubMed ID: 38669103
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mtor dual inhibitor.
    Wang S; Zhang D; Wang J; Peng X; Sun H; Ji Y; Yang Z; Bian X; Hou Y; Ge M; Liu Y
    J Neurooncol; 2024 May; 168(1):139-149. PubMed ID: 38662151
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
    Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
    BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors.
    Cheng Y; Dai Y; Tang H; Lu X; Xie J; Xie W; Zhang Q; Liu Y; Lin S; Yao H; Shang H; Yang K; Liu H; Wu X; Zhang J; Zhang X; Xue L; Wu ZB
    Acta Neuropathol Commun; 2024 Apr; 12(1):61. PubMed ID: 38637883
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.
    Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
    Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
    Schachenhofer J; Gruber VE; Fehrer SV; Haider C; Glatter S; Liszewska E; Höftberger R; Aronica E; Rössler K; Jaworski J; Scholl T; Feucht M
    Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12974. PubMed ID: 38562027
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine prostate cancer.
    Wang Y; Wu N; Li J; Liang J; Zhou D; Cao Q; Li X; Jiang N
    Pharmacol Res; 2024 May; 203():107162. PubMed ID: 38554788
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. DNA damage-regulated autophagy modulator 1 prevents glioblastoma cells proliferation by regulating lysosomal function and autophagic flux stability.
    Zhang H; Luan L; Li X; Sun X; Yang K
    Exp Cell Res; 2024 Apr; 437(2):114016. PubMed ID: 38537746
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach.
    Kartal B; Denizler-Ebiri FN; Güven M; Taşpınar F; Canpınar H; Çetin S; Karaduman T; Küççüktürk S; Castresana J; Taşpınar M
    Med Oncol; 2024 Mar; 41(5):97. PubMed ID: 38532150
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.
    Lee YH; Yoon AR; Yun CO; Chung KC
    J Biol Chem; 2024 Apr; 300(4):107206. PubMed ID: 38519031
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
    Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
    World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 110.